Spicing Up Pharmacology: A Review of Synthetic Cannabinoids From Structure to Adverse Events

作者: Colin Davidson , Jolanta Opacka-Juffry , Angel Arevalo-Martin , Daniel Garcia-Ovejero , Eduardo Molina-Holgado

DOI: 10.1016/BS.APHA.2017.05.001

关键词:

摘要: Recreational use of synthetic cannabinoids (SCB), a class novel psychoactive substances is an increasing public health problem specifically in Western societies, with teenagers, young adults, and the prison population being most affected. Some these SCB are analogs tetrahydrocannabinol, aminoalkylindoles, other phytocannabinoid have been detected herbal preparations generically called "Spice." Spice, "K2" or "fake cannabis" general term used for variable mixtures unknown ingredients chemical composition. highly potent CB1 cannabinoid receptor agonists falsely marketed sold as safe legal drugs. Here, we present overview endocannabinoid system, CB, structures activity at CB receptors. Finally, highlight psychological effects SCB, particularly on learning memory, adverse clinical including cardiovascular kidneys, CNS, psychosis. Taken together, it clear that many extremely dangerous major problem.

参考文章(168)
Fabrizio Schifano, Laura Orsolini, G. Duccio Papanti, John M. Corkery, Novel psychoactive substances of interest for psychiatry. World Psychiatry. ,vol. 14, pp. 15- 26 ,(2015) , 10.1002/WPS.20174
Supaart Sirikantaramas, Futoshi Taura, Satoshi Morimoto, Yukihiro Shoyama, Recent advances in Cannabis sativa research: biosynthetic studies and its potential in biotechnology. Current Pharmaceutical Biotechnology. ,vol. 8, pp. 237- 243 ,(2007) , 10.2174/138920107781387456
Kathryn A. Seely, Jeff Lapoint, Jeffery H. Moran, Liana Fattore, Spice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoids Progress in Neuro-psychopharmacology & Biological Psychiatry. ,vol. 39, pp. 234- 243 ,(2012) , 10.1016/J.PNPBP.2012.04.017
R. G. Pertwee, A. C. Howlett, M. E. Abood, S. P. H. Alexander, V. Di Marzo, M. R. Elphick, P. J. Greasley, H. S. Hansen, G. Kunos, K. Mackie, R. Mechoulam, R. A. Ross, International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2 Pharmacological Reviews. ,vol. 62, pp. 588- 631 ,(2010) , 10.1124/PR.110.003004
Erik W. Gunderson, Heather M. Haughey, Nassima Ait-Daoud, Amruta S. Joshi, Carl L. Hart, “Spice” and “K2” Herbal Highs: A Case Series and Systematic Review of the Clinical Effects and Biopsychosocial Implications of Synthetic Cannabinoid Use in Humans American Journal on Addictions. ,vol. 21, pp. 320- 326 ,(2012) , 10.1111/J.1521-0391.2012.00240.X
Masanobu Kano, Takako Ohno-Shosaku, Yuki Hashimotodani, Motokazu Uchigashima, Masahiko Watanabe, Endocannabinoid-Mediated Control of Synaptic Transmission Physiological Reviews. ,vol. 89, pp. 309- 380 ,(2009) , 10.1152/PHYSREV.00019.2008
Murray A. Mittleman, Rebecca A. Lewis, Malcolm Maclure, Jane B. Sherwood, James E. Muller, Triggering Myocardial Infarction by Marijuana Circulation. ,vol. 103, pp. 2805- 2809 ,(2001) , 10.1161/01.CIR.103.23.2805
Miquel Martin, Catherine Ledent, Marc Parmentier, Rafael Maldonado, Olga Valverde, Involvement of CB1 cannabinoid receptors in emotional behaviour. Psychopharmacology. ,vol. 159, pp. 379- 387 ,(2002) , 10.1007/S00213-001-0946-5
Ersan Tatli, Mustafa Yılmaztepe, Gurcan Altun, Armagan Altun, Cannabis-induced coronary artery thrombosis and acute anterior myocardial infarction in a young man International Journal of Cardiology. ,vol. 120, pp. 420- 422 ,(2007) , 10.1016/J.IJCARD.2006.08.012
Shi Di, Renato Malcher-Lopes, Katalin Cs. Halmos, Jeffrey G. Tasker, Nongenomic Glucocorticoid Inhibition via Endocannabinoid Release in the Hypothalamus: A Fast Feedback Mechanism The Journal of Neuroscience. ,vol. 23, pp. 4850- 4857 ,(2003) , 10.1523/JNEUROSCI.23-12-04850.2003